Bayesian Capital Management made a big biotech play, grabbing 43,000 shares of Amgen worth over $11 million, making it their ...

The Dow Jones Industrial Average is trading down Tuesday afternoon with shares of Merck and Amgen seeing the biggest declines for the blue-chip average.

Investors reacted negatively to the news. The company’s stock fell more than 16% yesterday. It’s also a setback in ...

Shares of Merck Merck & Co. Inc. and Amgen Amgen Inc. are contributing to the blue-chip gauge's intraday decline, as the Dow Dow Jones Industrial Average was most recently trading 378 points (0.9%) ...

The Dow Jones Industrial Average is falling Tuesday morning with shares of Merck and NVIDIA Corp. delivering the stiffest headwinds for the index. Shares of Merck and NVIDIA Corp. are contributing to ...

Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. Featuring daily updates of ...

Biosimilars are gaining traction as competitors aim to capture market share from branded biologics such as Humira and ...

Amgen's diverse portfolio ensures stability, but risks like high debt and biosimilar competition loom. Check out my look at ...